Journal
BURNS
Volume 35, Issue 2, Pages 171-180Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.burns.2008.03.009
Keywords
Liposomes; Non-viral gene therapy; Growth factors; Umbilical cord derived stem cells; Cutaneous stem cells
Categories
Funding
- Postdoctoral Training in Trauma and Burns program [T32-GM08256]
- Clayton Foundation for Research
- American Surgical Association Foundation
- Anderson Foundation
- Shriners Hospital for Children [8660, 8460]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087285, T32GM008256, P50GM060338, R01GM056687] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Different therapies that effect wound repair have been proposed over the last few decades. This article reviews the emerging fields of gene and stem cell therapy in wound healing. Gene therapy, initially developed for treatment of congenital defects, is a new option for enhancing wound repair. In order to accelerate wound closure, genes encoding for growth factors or cytokines showed the greatest potential. The majority of gene delivery systems are based on viral transfection, naked DNA application, high pressure injection, or liposomal vectors. Embryonic and adult stem cells have a prolonged self-renewal capacity with the ability to differentiate into various tissue types. A variety of sources, such as bone marrow, peripheral blood, umbilical cord blood, adipose tissue, skin and hair follicles, have been utilized to isolate stem cells to accelerate the healing response of acute and chronic wounds. Recently, the combination of gene and stem cell therapy has emerged as a promising approach for treatment of chronic and acute wounds. (C) 2008 Elsevier Ltd and ISBI. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available